Description: Sartorius Stedim Biotech SA provides cutting-edge equipment and services for the development, quality assurance and production processes of the biopharmaceutical industry. Its integrated solutions covering fermentation, cell cultivation, filtration, purification, fluid management and lab technologies are supporting the biopharmaceutical industry around the world to develop and produce drugs safely, timely and economically. It focuses on single-use technologies and value-added services to meet the rapidly changing technology requirements of the industry it serves. The company's extensive range of technologies, products and services helps customers to develop and manufacture medications and vaccines using biological methods. It also offers a range primarily consisting of consumables for the laboratory, including filters, bags and cell culture vessels. Sartorius Stedim Biotech was founded on September 28, 1978 and is headquartered in Aubagne, France.
Home Page: www.sartorius.com
Zone Industrielle Les Paluds
Aubagne,
13781
France
Phone:
33 4 42 84 56 00
Officers
| Name | Title |
|---|---|
| Dr. Joachim Kreuzburg | Chairman & CEO |
| Mr. Heiko Imöhl | VP of Group Financing & Investor Relations |
| Ms. Petra Kirchhoff | Head of Corp. Communications & IR |
| Mr. John Gerard Mackay | Exec. VP of Marketing, Sales & Services for Lab Products and Services Division |
| Benedikt Orzelek | Head of Investor Relations |
| Olivier Guitard | Head of Controlling BPS |
Exchange: PINK
Country: US
Currency: US Dollar ($)
| Forward PE: | 32.7869 |
|---|---|
| Trailing PE: | 41.9589 |
| Price-to-Book MRQ: | 13.5819 |
| Price-to-Sales TTM: | 9.6235 |
| IPO Date: | |
| Fiscal Year End: | December |
| Full Time Employees: | 10409 |